MedPath

A SINGLE CENTRE PROSPECTIVE STUDY TO EVALUATE THE EFFICACY (HYDRATE ,TONES, BRIGHTNESS AND RADIANCE) OF SOUNDARYA RADIANCE CREAM

Phase 4
Registration Number
CTRI/2022/03/041259
Lead Sponsor
Mountain Valley Springs India Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Healthy subjects (no infectious and evaluative pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory check-up)

2)Indian Male/Female subjects.

3)Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar etc)

4)Between 20 to 65 years of age, with normal skin condition.

5)Written informed consent signed by the subject in line with applicable regulation of country.

Exclusion Criteria

1)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis).

2)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products.

3)Having cutaneous hypersensitivity.

4)Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted).

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The criteria for the assessment of will be described in terms to evaluate specific parameters that hydrate, tones and bring brightness & radiance in skin care formulations (Soundarya Radiance cream) in healthy volunteer Evaluation will be based on: <br/ ><br>Subject�s self-assessment <br/ ><br>Dermatological evaluation by medically qualified study investigatorTimepoint: Subject Assessment will be done at 30 minutes, 20 days and 40 days after test product application
Secondary Outcome Measures
NameTimeMethod
Safety evaluation by the investigator will be done at the end of the study.Timepoint: 40 days
© Copyright 2025. All Rights Reserved by MedPath